Septerna, Inc. cotiza a 37.56 USD y tiene una capitalización bursátil de $1.8B. En los últimos 12 meses ha facturado $99M con un margen de flujo de caja libre del 238.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists fo…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.29 | $-0.19 | $-0.24 |
| Estimado | $-0.55 | $-0.49 | $-0.44 | $-0.22 |
| Sorpresa | — | +40.8% | +56.8% | -9.1% |
| Métrica | SEPN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -148.6% | -38.6% | -110.0% |
| Net Margin | -106.4% | -33.6% | -72.8% |
| FCF Margin | 238.7% | -13.9% | +252.5% |
| ROE | -12.8% | -40.4% | +27.6% |
| ROA | -8.2% | -32.0% | +23.8% |
| Current Ratio | 4.73 | 2.84 | +1.89 |
| Debt / Equity | — | 0.28 | — |